Daniel Chao is a medtech entrepreneur, specializing in devices that retune the brain. Currently, Dr. Chao is co-founder and CEO of Halo Neuroscience, a venture backed start-up based in San Francisco developing a novel, simple, and powerful neuroscience-based technology for optimizing brain performance for the healthy and impaired. Prior to Halo, Dr. Chao was the Head of Business Development at NeuroPace where he played a central role in the development of the world’s first closed-loop neuromodulation device for the treatment of epilepsy. Dr. Chao was a consultant at McKinsey & Company in their New York office and received his M.D. and M.S. in neuroscience from Stanford University.